What is Cycle Pharma?
Cycle Pharmaceuticals operates at the intersection of drug repurposing and therapeutic innovation. By focusing on the optimization of existing treatments and the development of novel formulations, the company addresses critical unmet medical needs for patients suffering from rare, often genetic, conditions. Beyond its core pharmaceutical portfolio, Cycle Pharma distinguishes itself through a holistic patient-centric model. This includes integrated support services such as nutritional guidance and comprehensive assistance programs, which are designed to improve the quality of life for both patients and their caregivers. The company's market position is defined by its ability to bridge the gap between complex clinical research and practical, accessible patient care, effectively scaling its footprint in the global life sciences sector.
How much funding has Cycle Pharma raised?
Cycle Pharma has raised a total of $25M across 1 funding round:
Debt
$25M
Debt (2020): $25M with participation from Deutsche Bank AG
Key Investors in Cycle Pharma
Deutsche Bank AG
A global financial institution providing comprehensive corporate and investment banking services, including debt origination and risk management solutions for large-scale enterprise clients.
What's next for Cycle Pharma?
With this major enterprise-level funding, Cycle Pharma is well-positioned to accelerate its clinical pipeline and expand its commercial reach. The strategic allocation of these resources will likely focus on scaling manufacturing processes and enhancing the reach of its patient support infrastructure. As the company continues to refine its therapeutic offerings, the focus will remain on navigating regulatory landscapes in both the UK and US markets to ensure rapid delivery of life-altering medications. Future growth will likely be driven by the successful commercialization of its current pipeline and the potential for further strategic partnerships to broaden its immunological and metabolic research capabilities.
See full Cycle Pharma company page
